Skip to main content
OpenTrials

Clinical trial condition

Lung Diseases, Obstructive

Explore clinical trials studying Lung Diseases, Obstructive. Study availability and eligibility vary by location and protocol.

7,959 public trials 737 recruiting studies
Refine in advanced search Browse all conditions

Lung Diseases, Obstructive trial results

Completed

Trial Comparing Tiotropium Inhalation Capsules vs Placebo in Chronic Obstructive Pulmonary Disease (COPD).

NCT00523991

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • 205.365.1003 Boehringer Ingelheim Investigational Site Birmingham, Alabama, United States
  • 205.365.1004 Boehringer Ingelheim Investigational Site Birmingham, Alabama, United States
  • 205.365.1098 Boehringer Ingelheim Investigational Site Jasper, Alabama, United States
  • 205.365.1023 Boehringer Ingelheim Investigational Site Palo Alto, California, United States
View all 62 locations
View Trial Details
Completed

Tiotropium / Respimat One-Year Study

NCT00168844

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • Boehringer Ingelheim Investigational Site Los Angeles, California, United States
  • Boehringer Ingelheim Investigational Site Pismo Beach, California, United States
  • Boehringer Ingelheim Investigational Site San Diego, California, United States
  • Boehringer Ingelheim Investigational Site Fort Collins, Colorado, United States
View all 72 locations
View Trial Details
Completed

Tiotropium / Respimat One-Year Study

NCT00168831

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • Boehringer Ingelheim Investigational Site Birmingham, Alabama, United States
  • Boehringer Ingelheim Investigational Site La Jolla, California, United States
  • Boehringer Ingelheim Investigational Site Long Beach, California, United States
  • Boehringer Ingelheim Investigational Site San Luis Obispo, California, United States
View all 76 locations
View Trial Details
Completed

Evaluation of the Long- Term Effects of Spiriva on Lung Function in COPD Patients

NCT00144339

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • 205.235.3779 Boehringer Ingelheim Investigational Site Anniston, Alabama, United States
  • 205.235.3785 Boehringer Ingelheim Investigational Site Birmingham, Alabama, United States
  • 205.235.3804 Boehringer Ingelheim Investigational Site Jasper, Alabama, United States
  • 205.235.3795 Boehringer Ingelheim Investigational Site Mobile, Alabama, United States
View all 490 locations
View Trial Details
Completed

Efficacy and Safety of 3 Doses of Tiotropium Compared to Placebo in Adolescents (12 to 17 Yrs) With Moderate Asthma

NCT01122680

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • 205.424.01002 Boehringer Ingelheim Investigational Site Denver, Colorado, United States
  • 205.424.01006 Boehringer Ingelheim Investigational Site Columbia, Missouri, United States
  • 205.424.01007 Boehringer Ingelheim Investigational Site Warrensburg, Missouri, United States
  • 205.424.01004 Boehringer Ingelheim Investigational Site Boys Town, Nebraska, United States
View all 19 locations
View Trial Details
Completed

Tiotropium Respimat Pharmacokinetic Study in COPD

NCT01222533

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • 205.458.32003 Boehringer Ingelheim Investigational Site Genk, Belgium
  • 205.458.32001 Boehringer Ingelheim Investigational Site Ghent, Belgium
  • 205.458.32002 Boehringer Ingelheim Investigational Site Hasselt, Belgium
  • 205.458.45001 Boehringer Ingelheim Investigational Site Copenhagen K, Denmark
View Trial Details
Completed

A Trial Comparing Treatment With Tiotropium Inhalation Capsules to Combivent Inhalation Aerosol in COPD Patients.

NCT00359788

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • 205.325.904 Boehringer Ingelheim Investigational Site Birmingham, Alabama, United States
  • 205.325.925 Boehringer Ingelheim Investigational Site Phoenix, Arizona, United States
  • 205.325.909 Boehringer Ingelheim Investigational Site Tucson, Arizona, United States
  • 205.325.912 Boehringer Ingelheim Investigational Site Long Beach, California, United States
View all 31 locations
View Trial Details
Completed

Tiotropium and Salmeterol PK Study in COPD Patients

NCT00673478

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • 1184.24.32001 Boehringer Ingelheim Investigational Site Genk, Belgium
  • 1184.24.32002 Boehringer Ingelheim Investigational Site Hasselt, Belgium
  • 1184.24.31001 Boehringer Ingelheim Investigational Site Heerlen, Netherlands
View Trial Details

Related conditions